Literature DB >> 19621784

[Inflammatory bowel disease: IBD].

Katsuya Endo1, Hisashi Shiga, Yoshitaka Kinouchi, Tooru Shimosegawa.   

Abstract

Inflammatory bowel diseases (IBD) are chronic, relapsing inflammatory disorders of the gastrointestinal tract, which are represented mainly by ulcerative colitis and Crohn's disease. Although the cause of IBD remains unknown, immunological abnormalities triggered by genetic and environmental factors are thought to be important in its pathogenesis. Recently, the intestinal microflora have been thought to be an important and essential environmental factor in their etiology. There are two major hypotheses which explain the relationship between the intestinal microflora and the pathogenesis of IBD. The first hypothesis is that IBD are caused by abnormal immunological responses to the normal intestinal microflora. In this case, disorders of the mucosal innate immune systems, such as functional disorders of NOD, lead to excessive immune responses and cause mucosal inflammation of the gut. The second hypothesis is that IBD are caused by fundamental, abnormal changes in the intestinal microflora. In this case, the changes in the composition of the intestinal microflora lead to pathogenic responses and cause mucosal inflammation of the gut. Recently, molecular approaches that facilitate evaluation of alterations in non-cultivatable intestinal bacteria in IBD patients have supported the latter hypothesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19621784

Source DB:  PubMed          Journal:  Rinsho Byori        ISSN: 0047-1860


  7 in total

1.  Microbiota of Inflammatory Bowel Disease Models.

Authors:  Ziyang Gao; Kai-Yuan Chen; Olaf Mueller; Han Zhang; Nikolai Rakhilin; Jiande Chen; Xiling Shen
Journal:  Annu Int Conf IEEE Eng Med Biol Soc       Date:  2018-07

2.  Gene expression analysis of intestinal IL-8, IL-17 A and IL-10 in patients with celiac and inflammatory bowel diseases.

Authors:  Elham Aghamohamadi; Nastaran Asri; Aylin Odak; Mohammad Rostami-Nejad; Vahid Chaleshi; Yasaman Hajinabi; Maryam Eslami; Saeed Mohammadian Haftcheshmeh; Fahimeh Sadat Gholam-Mostafaei; Hamid Asadzadeh-Aghdaei; Andrea Masotti; Mohammad Reza Zali
Journal:  Mol Biol Rep       Date:  2022-05-08       Impact factor: 2.742

Review 3.  Overview of Three Proliferation Pathways (Wnt, Notch, and Hippo) in Intestine and Immune System and Their Role in Inflammatory Bowel Diseases (IBDs).

Authors:  Seyed Mobin Khoramjoo; Nesa Kazemifard; Shaghayegh Baradaran Ghavami; Maryam Farmani; Shabnam Shahrokh; Hamid Asadzadeh Aghdaei; Ghazal Sherkat; Mohammad Reza Zali
Journal:  Front Med (Lausanne)       Date:  2022-05-23

4.  Gingko biloba extract (Ginaton) ameliorates dextran sulfate sodium (DSS)-induced acute experimental colitis in mice via reducing IL-6/STAT3 and IL-23/IL-17.

Authors:  Yan Sun; Lian-Jie Lin; Yan Lin; Li-Xuan Sang; Min Jiang; Chang-Qing Zheng
Journal:  Int J Clin Exp Med       Date:  2015-10-15

5.  Lack of Association between Interleukin 23R (IL-23R) rs10889677 Polymorphism and Inflammatory Bowel Disease Susceptibility In an Iranian Population.

Authors:  Sara Karimkhani; Vahid Chaleshi; Hedieh Balaii; Peyman Tarban; Mahyar Nourian; Shiva Irani; Shabnam Shahrokh; Hamid Asadzadeh Aghdaei; Amir Houshang Mohammad Alizadeh; Mohsen Norouzinia; Mohammad Reza Zali
Journal:  Rep Biochem Mol Biol       Date:  2018-10

Review 6.  The role of mycobiota-genotype association in inflammatory bowel diseases: a narrative review.

Authors:  Elaheh Mahmoudi; Sayed-Hamidreza Mozhgani; Niusha Sharifinejad
Journal:  Gut Pathog       Date:  2021-05-08       Impact factor: 4.181

Review 7.  The relationship between intestinal parasites and some immune-mediated intestinal conditions.

Authors:  Rasoul Mohammadi; Ahmad Hosseini-Safa; Mohammad Javad Ehsani Ardakani; Mohammad Rostami-Nejad
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2015
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.